nCino, Inc. (NCNO) Financial Statements
nCino, Inc. (NCNO) reported trailing twelve-month revenue of $622.2M (up 8.6% year on year) and net income of $33.6M as of 2026-07-31, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $132.2M.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
NCNOnCino, Inc.Follow NCNO — free
—
Price chart with a free account
- Market cap
- 2.4B
- P/E TTM
- 74.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 25 Aug, in -60 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jul 26.
| Line | FY2022 Jan 22 | FY2023 Jan 23 | FY2024 Jan 24 | FY2025 Jan 25 | FY2026 Jan 26 | TTM Jul 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 0.27 | 0.41 | 0.48 | 0.54 | 0.59 | 0.62 | |
| Gross profit | 0.16 | 0.24 | 0.29 | 0.32 | 0.36 | 0.39 | |
| Research & development | 0.08 | 0.12 | 0.12 | 0.13 | 0.13 | 0.12 | |
| Operating income | -0.07 | -0.09 | -0.04 | -0.02 | 0.00 | 0.05 | |
| Pre-tax income | -0.07 | -0.10 | -0.04 | -0.04 | 0.01 | 0.03 | |
| Income tax | -0.02 | 0.00 | 0.00 | -0.00 | -0.00 | -0.01 | |
| Net income | -0.05 | -0.10 | -0.04 | -0.04 | 0.01 | 0.03 | |
| Diluted EPS ($) | -0.51 | -0.93 | -0.38 | -0.33 | 0.05 | 0.31 | |
| Diluted shares (bn) | 0.097 | 0.111 | 0.113 | 0.115 | 0.114 | — |
USD billions · SEC XBRL
nCino, Inc. — questions
- What is nCino, Inc.'s revenue?
- $622.2M over the twelve months to 2026-07-31, up 8.6% year on year, from its 10-Q and 10-K filings.
- What is nCino, Inc.'s net income?
- $33.6M over the twelve months to 2026-07-31.
- What is nCino, Inc.'s free cash flow?
- $132.2M over the twelve months to 2026-07-31.
- What are nCino, Inc.'s diluted earnings per share?
- $0.31 over the twelve months to 2026-07-31.
Every figure on this page comes from nCino, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.